Literature DB >> 8058285

Laser endoscope in the management of proliferative vitreoretinopathy.

M Uram1.   

Abstract

PURPOSE: To evaluate the ability of the ophthalmic laser microendoscope for improving the outcome of vitrectomy in the management of grade D3 anterior proliferative vitreoretinopathy.
METHODS: Ten consecutive patients without diabetes who had grade D3 anterior proliferative vitreoretinopathy underwent vitrectomy, lensectomy, membranectomy, gas-fluid exchange, and endophotocoagulation. Endoscopically guided portions of the vitrectomy and endophotocoagulation process were assessed, particularly in the region of the pars plana, ciliary body, posterior iris, and internal aspect of sclerotomy sites.
RESULTS: Follow-up ranged from 3 months to 1 year (mean, 9.2 months). Six of ten patients maintained total reattachment of the retina throughout the follow-up period. The retinas of the remaining patients redetached. Visual acuity for patients with reattached retinas ranged from 20/80 to hand motions.
CONCLUSION: Because endoscopy enhances the ability of the surgeon to image and dissect gliotic membranes in the regions of the pars plana, ciliary body, and posterior iris, as well as allow complete photocoagulation, a higher probability of anatomic success seems possible.

Entities:  

Mesh:

Year:  1994        PMID: 8058285     DOI: 10.1016/s0161-6420(94)31157-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

Review 1.  Endoscopy-assisted vitrectomy in the anterior vitreous.

Authors:  Yong-Zhen Yu; Yu-Ping Zou; Xiu-Lan Zou
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

2.  Endoscope-assisted goniosynechialysis combined with phacoemulsification and intraocular lens implantation to manage primary angle-closure glaucoma.

Authors:  Jing Chen; Yu-Ping Zou
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

Review 3.  Intraocular endoscopy: A review.

Authors:  Vivek Pravin Dave; Mudit Tyagi; Raja Narayanan; Rajeev Reddy Pappuru
Journal:  Indian J Ophthalmol       Date:  2021-01       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.